JP2025504219A5 - - Google Patents
Info
- Publication number
- JP2025504219A5 JP2025504219A5 JP2024547249A JP2024547249A JP2025504219A5 JP 2025504219 A5 JP2025504219 A5 JP 2025504219A5 JP 2024547249 A JP2024547249 A JP 2024547249A JP 2024547249 A JP2024547249 A JP 2024547249A JP 2025504219 A5 JP2025504219 A5 JP 2025504219A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- sildenafil
- pde5
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW111104639A TWI859506B (zh) | 2022-02-09 | 2022-02-09 | 化合物組合用於製作血管疾病治療藥的用途 |
| TW111104639 | 2022-02-09 | ||
| PCT/GB2023/050296 WO2023152500A1 (en) | 2022-02-09 | 2023-02-09 | Combination of compounds for treating vascular diseases comprising pde5 inhibitor, arginine and n-acetylcysteine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504219A JP2025504219A (ja) | 2025-02-06 |
| JP2025504219A5 true JP2025504219A5 (https=) | 2026-02-13 |
Family
ID=85283927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547249A Pending JP2025504219A (ja) | 2022-02-09 | 2023-02-09 | Ｐｄｅ５阻害剤、アルギニン、及びｎ－アセチルシステインを含む、血管疾患を治療するための化合物の組合せ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250134892A1 (https=) |
| EP (1) | EP4475833A1 (https=) |
| JP (1) | JP2025504219A (https=) |
| KR (1) | KR20240146018A (https=) |
| CN (1) | CN116808224A (https=) |
| AU (1) | AU2023219232A1 (https=) |
| TW (1) | TWI859506B (https=) |
| WO (1) | WO2023152500A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025046207A1 (en) * | 2023-08-31 | 2025-03-06 | Future Pharmtech Inc. | New use of a pde 5 inhibitor combination in promoting neurite outgrowth |
| TWI879058B (zh) * | 2023-08-31 | 2025-04-01 | 未來新藥股份有限公司 | Pde5抑制劑組合於促進神經突生長之新穎用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4699299A (en) | 1998-06-26 | 2000-01-17 | Nutracorp Scientific, Inc. | Promoting nitric oxide and cyclic gmp activity |
| IL132460A0 (en) * | 1999-10-19 | 2001-03-19 | Laniado Shlomo | Sildenafil preparation |
-
2022
- 2022-02-09 TW TW111104639A patent/TWI859506B/zh active
-
2023
- 2023-02-09 AU AU2023219232A patent/AU2023219232A1/en active Pending
- 2023-02-09 CN CN202310100652.1A patent/CN116808224A/zh active Pending
- 2023-02-09 KR KR1020247028842A patent/KR20240146018A/ko active Pending
- 2023-02-09 US US18/836,532 patent/US20250134892A1/en active Pending
- 2023-02-09 EP EP23706081.9A patent/EP4475833A1/en active Pending
- 2023-02-09 WO PCT/GB2023/050296 patent/WO2023152500A1/en not_active Ceased
- 2023-02-09 JP JP2024547249A patent/JP2025504219A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023088944A5 (https=) | ||
| JP2025504219A5 (https=) | ||
| CA2749730C (en) | Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction | |
| JP2009514874A5 (https=) | ||
| US10265314B2 (en) | SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis | |
| US20120157472A1 (en) | Method for treating colorectal cancer | |
| JP2015535264A (ja) | コルヒチン誘導体の投与による心血管イベントの処置または予防 | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| IL274836B1 (en) | Dosing schedule for vidoplodimes for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases | |
| JP2022546980A5 (https=) | ||
| JP2019536812A5 (https=) | ||
| Rashid | The efficacy and safety of PDE5 inhibitors | |
| JP2007506752A (ja) | 肺動脈高血圧症を治療するための併用療法におけるイロプロスト | |
| CN107580495A (zh) | 单独和与PDE5抑制剂组合的sGC刺激剂、sGC活化剂用于治疗伴随系统性硬化症(SSc)的指溃疡(DU)的用途 | |
| JP2023500032A5 (https=) | ||
| JP2007169278A (ja) | Ｌｕｔｓ処置用の医薬組合せ | |
| JP2020523334A5 (https=) | ||
| JP2009518415A5 (https=) | ||
| RU2334517C2 (ru) | Средство, потенцирующее противоопухолевый эффект, и противоопухолевое средство | |
| JP2025509278A5 (https=) | ||
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| JP2024540439A5 (https=) | ||
| ES2309357T3 (es) | Nueva combinacion sinergica que comprende roflumilast y formoterol. | |
| JP2023504115A5 (https=) | ||
| AU2021321535A1 (en) | Compositions and methods for treating or preventing disease associated with beta coronavirus infection |